← Evidence map

ReviewOncotarget2016

CRISPR/Cas9 and cancer targets: future possibilities and present challenges.

Martyn K White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26840090